Shop Apotheke Europe (ETR:SAE) has been assigned a €52.00 ($60.47) target price by equities research analysts at Deutsche Bank in a research report issued to clients and investors on Friday, Borsen Zeitung reports. The firm currently has a “buy” rating on the stock. Deutsche Bank’s target price indicates a potential upside of 31.15% from the stock’s current price.
Other equities research analysts also recently issued reports about the company. Hauck & Aufhaeuser set a €51.00 ($59.30) target price on Shop Apotheke Europe and gave the company a “buy” rating in a report on Thursday. Kepler Capital Markets set a €46.00 ($53.49) price target on Shop Apotheke Europe and gave the company a “buy” rating in a research report on Monday, April 1st. Finally, Commerzbank set a €42.00 ($48.84) price target on Shop Apotheke Europe and gave the stock a “neutral” rating in a research note on Friday, March 15th.
SAE opened at €39.65 ($46.10) on Friday. The company has a debt-to-equity ratio of 40.94, a current ratio of 2.55 and a quick ratio of 1.52. The firm has a market cap of $478.77 million and a PE ratio of -14.21. Shop Apotheke Europe has a fifty-two week low of €34.40 ($40.00) and a fifty-two week high of €56.00 ($65.12).
Shop Apotheke Europe Company Profile
Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Austria, Belgium, the Netherlands, France, Italy, and Spain. The company provides non-prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. It operates under the shop-apotheke.com brand in Germany; shop-apotheke.at brand in Austria; shop-pharmacie.fr brand in France; and farmaline brand in Belgium, Italy, and Spain.
Featured Story: How is the S&P 500 index different from the DJIA?
Receive News & Ratings for Shop Apotheke Europe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shop Apotheke Europe and related companies with MarketBeat.com's FREE daily email newsletter.